MedPath

effect of milk thistle extract, curcumin, n-acetylcystein, artichoke extract, vitamin D, and Chromium on non-alcoholic fatty liver

Phase 3
Recruiting
Conditions
Fatty liver.
Fatty (change of) liver, not elsewhere classified
K76.0
Registration Number
IRCT20140804018677N27
Lead Sponsor
Samanik Salamat Gostar Company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
33
Inclusion Criteria

Fatty liver diagnosis based on sonography
Age>18 years
Willing to participate in the study

Exclusion Criteria

Having known kidney disease
Having known heart disease
Pregnancy or lactation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Alanine Aminotransferase (ALT) enzyme. Timepoint: Baseline and at the end of the study. Method of measurement: Biochemical kit.;Aspartate transaminase (AST) enzyme. Timepoint: Baseline and at the end of the study. Method of measurement: Biochemical kit.;Fibrosis-4 (FIB-4). Timepoint: Baseline and at the end of the study. Method of measurement: Biochemical kit.;AST to Platelet Ratio Index (APRI). Timepoint: Baseline and at the end of the study. Method of measurement: Calculation based on biochemical kit.;Alkaline phosphatase (Alk-ph) enzyme. Timepoint: Baseline and at the end of the study. Method of measurement: Biochemical kit.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath